Register for upcoming webinars and access previous webinar recordings
In this event, we will be joined by John Squeo, Blockchain Lead at Accenture specializing in Healthcare and Life Sciences. We will be discussing how companies are evaluating the ROI behind implementing blockchain in their revenue management processes, specifically the contracting and chargebacks process between manufacturers, wholesalers and GPOs.
In this event, we walked through an example implementation of the Contracts & Chargebacks Solution on the MediLedger Network. We intended this event to be compelling for both Business and IT leaders who are interested in driving innovation through blockchain but don’t have a clear path to adoption.
We hosted a new type of virtual event we called the MediLedger Cafe, where the focal point was audience questions, participation and debate. The topic was Blockchain in the Life Sciences industry and the MediLedger Network. See the results of the webinar polls in the presentation or the live recording of the webinar.
This event focused on how early solutions on the MediLedger Network become the building blocks for future use cases on the roadmap and how the network becomes a platform for companies and their trading partners throughout the Life Sciences and Healthcare industry.
In this webinar we discussed the root challenges that lead to pricing issues for GPO member hospitals, pharmacies and clinics through the chargeback process in the pharmaceutical industry. We then addressed the role of blockchain in resolving these issues between GPOs, manufacturers and wholesalers.
In this webinar we did a deep dive into the process of customer management, identification and eligibility determination in the Contracts & Chargebacks solution on MediLedger. We specifically covered customer identification and mapping from the GPO roster, Integrated 3rd party identification data, and the customizable customer evaluation engine for manufacturers.
The focus of this event was how the MediLedger Network can bring new levels of automation to the contracting and chargebacks process in the pharmaceutical industry, including an overview of the current challenges in the industry, and blockchain's role in solving these challenges.
This webinar event discussed next steps after the conclusion of the MediLedger DSCSA FDA pilot. Including upcoming DSCSA requirements, current solutions solving real business problems today and the role of working groups in developing blockchain-powered products.
